Obinutuzumab
Update Venetoclax in CLL
Zanubrutinib
(Update) Acalabrutinib in CLL and MCL
NCCN Guidelines for Patients for CLL
ASCO: COVID-19 Medical Resources
ASH: COVID-19 Resources for Managing Blood Cancers
JADPRO Roundtable Series: Best Practices in the Use of BTK Inhibitors in CLL